Products

What will AGI do for Astromicin?

This classification denotes an aminoglycoside antibiotic with the molecular formula C17H35N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7JHD84H15J, chemically known as 2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-(1-aminoethyl)tetrahydropyran-2-yl]oxy-2,5-dihydroxy-6-methoxy-cyclohexyl]-N-methyl-acetamide but generally known as astromicin, which bears US NIH Compound Identifier 65345. European Medicines Agency schedules Astromicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05587MIG. Most nations schedule astromicin under HS 29419000 and SITC 54139. As of Q4 2014, ASTROMICIN remains the US FDA Preferred Term for this commodity. Astromicin bears US NLM identifiers UMLS ID C0060685 and NCI Concept Code C76146. SMILES: CC(C1CCC(C(O1)OC2C(C(C(C(C2O)N(C)C(=O)CN)OC)O)N)N)N.